Association of core-binding factor β with the malignant phenotype of prostate and ovarian cancer cells-Reference-Cited by-同舟云学术

Association of core-binding factor β with the malignant phenotype of prostate and ovarian cancer cells

Published:2010-12 Issue:3 Volume:225 Page:875-887
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J. Cell. Physiol.

Author:

Davis J. Nathan,Rogers Donna,Adams Lisa,Yong Thomas,Jung Jette S.,Cheng Bing,Fennell Katie,Borazanci Erkut,Moustafa Yara W.,Sun Amanda,Shi Runhua,Glass Jonathan,Mathis J. Michael,Williams B. Jill,Meyers Shari

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcp.22298/fullpdf

Reference59 articles.

1. The leukemic protein core binding factor beta (CBFbeta)-smooth-muscle myosin heavy chain sequesters CBFalpha2 into cytoskeletal filaments and aggregates;Adya;Mol Cell Biol,1998

2. Function of CBFbeta/Bro proteins;Adya;Semin Cell Dev Biol,2000

3. Runx2 association with progression of prostate cancer in patients: Mechanisms mediating bone osteolysis and osteoblastic metastatic lesions;Akech;Oncogene,2009

4. Involvement of members of the cadherin superfamily in cancer;Berx;Cold Spring Harb Perspect Biol,2009

5. The RUNX genes: Gain or loss of function in cancer;Blyth;Nat Rev Cancer,2005

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intracellular zinc protects tumours from T cell-mediated cytotoxicity;Cell Death & Differentiation;2024-09-11

2. Transcranial direct‐current stimulation confers neuroprotection by regulating isoleucine‐dependent signalling after rat cerebral ischemia–reperfusion injury;European Journal of Neuroscience;2023-07-15

3. The RUNX/CBFβ Complex in Breast Cancer: A Conundrum of Context;Cells;2023-02-16

4. Cancer-Associated Exosomal CBFB Facilitates the Aggressive Phenotype, Evasion of Oxidative Stress, and Preferential Predisposition to Bone Prometastatic Factor of Breast Cancer Progression;Disease Markers;2022-07-19

5. AM22, a novel synthetic microRNA, inhibits the proliferation of colorectal cancer cells by targeting core binding factor subunit β (CBFB);Investigational New Drugs;2022-01-05